References
- Collaborative Normal Tension Glaucoma Study GroupComparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressureAm J Ophthalmol19981264874979780093
- Collaborative Normal Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol19981264985059780094
- NoureddinBNPoinoosawmyDFietzkeFWHitchinqsRARegression analysis of visual field progression in low tension glaucomaBr J Ophthalmol1991754934951873271
- The Advanced Glaucoma Intervention Study InvestigatorsAdvanced Glaucoma Intervention Study 2. Visual field test scoring and reliabilityOphthalmology1994101144514557741836
- McNaughtALCrabbDPFitzkeFWHitchinqsRAVisual field progression: Comparison of Humphrey Statpac 2 and pointwise linear regression analysisGraefes Arch Clin Exp Ophthalmol19962344114188817283
- FlammerJDranceSMAuqustinyLFunkhouserAQuantification of glaucomatous visual field defects with automated perimetryInvest Ophthalmol Vis Sci1985261761813972500
- TomitaGAraieMKitazawaYTsukaharaSA three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patientsEye20041898498915037889
- InoueKWakakuraMInoueJTomitaGEffect of nipradilol instillation for three years in eyes with normal-tension glaucomaJpn J Clin Ophthalmol200862323327
- KalaboukhovaLFridhammarVLindblomBGlaucoma follow-up by the Heidelberg retina tomograph – new graphical analysis of optic disc topography changesGraefes Arch Clin Exp Ophthalmol200624465466216220279
- HarjuMSaariJKurvinenLVestiEReversal of optic disc cupping in glaucomaBr J Ophthalmol20089290190518577639
- UchidaYNakamuraMShimizuSShirasawaYFujiiMVasoactive and beta-adrenoceptor blocking properties of 3, 4-dihydro-8- (2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agentArch Int Pharmacodyn Ther19832621321496135395
- OhiraAWadaYFujiiMEffects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissuesArch Int Pharmacodyn Ther198527861712869737
- KannoMAraieMTomitaKSawanoboriKEffects of nipradilol, a β-blocking agent with α-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulationInvest Ophthalmol Vis Sci1998397367439538880
- KannoMAraieMKoibuchiHMasudaKEffects of topical nipradilol, a β blocking agent with α blocking and nitroglycerin-like activities, on intraocular pressure and aqueous dynamics in humansBr J Ophthalmol20008429329910684841
- YukawaETaketaniFMatsuuraTOcular hypotensive effect of nipradilol ophthalmic solution for normal-tension glaucomaJpn J Clin Ophthalmol20035714711475
- AraieMShiratoSYamazakiYClinical efficacy of topical nipradilol and timolol on visual field performance in normal-tension glaucoma: A multicenter, randomized, double-masked comparative studyJpn J Ophthalmol20085225526418773262
- TaniaiMSatoEMizotaAAdachi-UsamiEProtective action of nipradilol against ischemia-induced retinal damage in ratsOphthalmic Res20023433133712483019
- MizunoKKoideTSaitoNTopical nipradilol: Effects on optic nerve head circulation in humans and periocular distribution in monkeysInvest Ophthalmol Vis Sci2002433243325012356831
- KashiwagiKLizukaYTsukaharaSNeuroprotective effects of nipradilol on purified cultured retinal ganglion cellsJ Glaucoma20021123123812140401
- MizunoKKoideTYoshimuraMAraieMNeuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative actionInvest Ophthalmol Vis Sci20014268869411222528